FDA grants breakthrough device status to Teleflex’s coronary scaffold
Teleflex is currently evaluating Freesolve in the BIOMAG-III Pivotal Trial to support a future premarket approval application.
Teleflex is currently evaluating Freesolve in the BIOMAG-III Pivotal Trial to support a future premarket approval application.
The British government will now change up AI-enabled medical device regulation to encourage innovation with the appropriate guardrails.
The medical devices industry continues to be a hotbed of patent innovation. Activity is driven by increased need for homecare,...
Drug delivery’s next bottleneck isn’t innovation, it’s industrial capacity
Australia starts investigation into OpenAI Medicare breach
Industry partnership will determine the success of the transition to low-GWP pMDIs
UK government champions healthtech through new NHS access programme